O-(N-ACETYL-.ALPHA.-NEURAMINOSYL)-(2->3)-O-.BETA.-D-GALACTOPYRANOSYL-(1->3)-O-2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL-(1->3)-O-.ALPHA.-D-GALACTOPYRANOSYL-(1->4)-O-.BETA.-D-GALACTOPYRANOSYL-(1->4)-.BETA.-D-GLUCOPYRANOSE

UNII:	57Q49EEP2Y
Type:	INGREDIENT SUBSTANCE
Formula:	C₄₃H₇₂N₂O₃₄
Preferred Substance Name:	O-(N-ACETYL-.ALPHA.-NEURAMINOSYL)-(2->3)-O-.BETA.-D-GALACTOPYRANOSYL-(1->3)-O-2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL-(1->3)-O-.ALPHA.-D-GALACTOPYRANOSYL-(1->4)-O-.BETA.-D-GALACTOPYRANOSYL-(1->4)-.BETA.-D-GLUCOPYRANOSE
InChIKey:	CVJMMLQZMVLCDY-JIRPOHLFSA-N
GSRS Full Record:	57Q49EEP2Y i

1801921-94-7
O-(N-Acetyl-α-neuraminosyl)-(2→3)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→3)-O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranose
SSEA-4 hexaose
Stage-Specific Embryonic Antigen-4
β-D-Glucopyranose, O-(N-acetyl-α-neuraminosyl)-(2→3)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→3)-O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

O-(N-ACETYL-.ALPHA.-NEURAMINOSYL)-(2->3)-O-.BETA.-D-GALACTOPYRANOSYL-(1->3)-O-2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL-(1->3)-O-.ALPHA.-D-GALACTOPYRANOSYL-(1->4)-O-.BETA.-D-GALACTOPYRANOSYL-(1->4)-.BETA.-D-GLUCOPYRANOSE

Synonyms and Mappings

Resources